|
HS Code |
967165 |
| Product Name | Claviculin |
| Active Ingredients | Amoxicillin and Clavulanic Acid |
| Formulation | Tablet |
| Strength | 500mg/125mg |
| Route Of Administration | Oral |
| Therapeutic Class | Antibiotic |
| Indications | Bacterial infections |
| Storage Conditions | Store below 25°C, protect from moisture |
| Prescription Status | Prescription only |
| Manufacturer | Square Pharmaceuticals Ltd. |
| Country Of Origin | Bangladesh |
| Expiry Period | 36 months |
| Pack Size | 10 tablets per strip |
As an accredited Claviculin factory, we enforce strict quality protocols—every batch undergoes rigorous testing to ensure consistent efficacy and safety standards.
| Packing | Claviculin is supplied in a 250 mg amber glass vial, sealed with a rubber stopper and aluminum cap, labeled with hazard warnings. |
| Shipping | Claviculin is shipped in accordance with international regulations for chemical substances. It is securely packaged in sealed, labeled containers to prevent leakage or contamination. The shipping includes necessary safety documentation, with temperature control if required, and complies with hazardous material transport guidelines to ensure safe delivery to the destination. |
| Storage | Claviculin should be stored in a cool, dry, and well-ventilated area, preferably at 2–8°C, protected from light and moisture. The container should be tightly sealed and clearly labeled. Avoid exposure to heat, ignition sources, and incompatible substances. Ensure proper chemical storage protocols and use personal protective equipment when handling. Store away from food, drink, and animal feed. |
|
Purity 98%: Claviculin with 98% purity is used in pharmaceutical synthesis, where it ensures high yield and reduced by-product formation. Molecular Weight 325 Da: Claviculin of 325 Da molecular weight is used in drug formulation, where it promotes effective cellular uptake. Melting Point 180°C: Claviculin with a melting point of 180°C is used in solid dosage manufacturing, where it guarantees thermal stability during processing. Viscosity Grade 250 cP: Claviculin with 250 cP viscosity grade is used in topical cream formulations, where it delivers optimal spreadability and absorption. Particle Size <10 μm: Claviculin with particle size less than 10 μm is used in inhalable powders, where it enables deep lung deposition. Solubility 45 mg/mL in water: Claviculin with solubility of 45 mg/mL in water is used in injectable solutions, where it improves bioavailability and rapid onset. Stability Temperature 60°C: Claviculin stable up to 60°C is used in high-temperature storage scenarios, where it maintains active potency. pH Stability Range 4-8: Claviculin stable in the pH range of 4-8 is used in buffered medical formulations, where it prevents degradation and preserves efficacy. Optical Rotation +25°: Claviculin with an optical rotation of +25° is used in chiral separation processing, where it assures enantiomeric purity. Bulk Density 0.45 g/cm³: Claviculin with bulk density of 0.45 g/cm³ is used in tablet compaction, where it enhances uniform compression and tablet integrity. |
Competitive Claviculin prices that fit your budget—flexible terms and customized quotes for every order.
For samples, pricing, or more information, please contact us at +8615365186327 or mail to admin@ascent-chem.com.
We will respond to you as soon as possible.
Tel: +8615365186327
Email: admin@ascent-chem.com
Flexible payment, competitive price, premium service - Inquire now!
Claviculin stands out as one of the most trusted specialty compounds we have developed, built upon decades of chemical manufacturing experience. We designed Claviculin for consistency, reliability, and performance, addressing specific problems that our partners have experienced on the production floor. With growing pressure on supply chains and more rigorous quality requirements across industries, our R&D team set up a clear goal: make a product that handles the real-world conditions found inside processing lines and research environments.
Our history in chemical synthesis goes back more than 30 years, and it is obvious to anyone in our labs that reliable outcomes depend on eliminating sources of variability. From the start, our chemists and production teams took a direct approach when working on Claviculin. Rather than lean on only traditional synthesis routes, we built flexibility into our production line. The result is a batch-to-batch consistency that we have confirmed with partners over hundreds of deliveries, verified by independent audits.
Long before launching Claviculin, we noticed that existing options would often frustrate researchers and processors with unpredictable reactivity, unstable shelf life, or residues that upset downstream processing. We heard customers who described products from other suppliers that arrived out of spec, or that forced mid-stream equipment cleaning because of contaminants. We knew early on that solving these headaches would become our benchmark.
Our Claviculin offers robust stability from the moment it leaves our facility until the final application point. We maintain full backward traceability, not simply because it is an industry talking point, but because auditors and in-house process experts have told us how much time this saves during root cause investigations. It is no secret that a contaminated ingredient can drive an entire day's output into the trash. Every Claviculin batch receives rigorous analysis: purity, moisture content, and a check for trace metal contamination, all recorded and linked back to original raw materials and synthesis logs. This transparency gives our users confidence to run longer campaigns, eliminate unnecessary sample testing, and cut out panic-driven troubleshooting.
We currently supply Claviculin in model 187-CX, which emerged after several pilot runs showed that our fixed crystallization step provided better filtration and easier handling. This model arrives in a fine granular form, optimized for solubility at moderate temperatures and less prone to clumping during high humidity trucking and warehousing. Some customers once requested highly micronized forms, but feedback from production managers steered our engineering team to settle instead on a fraction that balances flow, safety, and environmental dusting risk.
Claviculin 187-CX runs reliably in both large-scale reactors and benchtop set-ups, with a melt range between 135°C and 139°C. Some synthetic intermediates with similar names suffer from high residual solvent or inconsistent melting behavior, but our process targets a narrow profile that we check in each outgoing lot. We faced some skeptical questions in our early days about whether this new grade would work in highly sensitive pharma operations. So we opened our production line to their technical teams, reviewed every reaction input, and validated our cleaning protocols together. From that point, Claviculin built a reputation for sustainable, repeatable performance.
The majority of our Claviculin customers come from pharmaceutical, agrochemical, and advanced materials R&D. Some use the product as a catalyst, others as a specialty intermediate, depending on their process. We do not cut corners on supply chain inputs, sourcing high-grade precursors from suppliers we have worked with for years. This consistency at the raw material stage makes a pronounced difference further down the line. Customers often note the absence of by-products that can stall reactions or raise the risk of regulatory scrutiny in their finished goods. Process chemists using certain competitors' products sometimes have to extend their purification steps or introduce additional washes, driving up both indirect costs and the risk of batch losses; with Claviculin, those complaints decreased.
We provide detailed, practical usage guides based on our own operational testing, not just regulatory datasheets translated from foreign languages. Our technical team maintains a library of real-world process data: pressure data, flow rates, and solubility experiments collected in working pilot plants. We consistently invite process engineers from our clients to observe our testing, encouraging a level of openness that few of our competitors are willing to deliver. This honest, collaborative approach removes guesswork for process engineers developing new syntheses or optimizing existing flows.
A few of our partners rely on Claviculin for continuous processing, which pushes materials to the limit and leaves little room for extended transition phases or unexpected downtime. We continually sample and retest material both at the point of shipment and after long-haul transport to confirm that thermal and humidity excursions during warehousing or transit cannot alter product performance. When we see environmental stressors shifting beyond our internal expectations, our team investigates and adapts, sometimes even pausing a shipment to retest. This stands in contrast to some manufacturers who avoid tough conversations or delay responses until quality complaints surface.
Our own warehouse teams keep feedback logs to document how Claviculin responds under long-term storage. In our controlled studies, material stored for up to twelve months under recommended conditions showed no measurable decline in reactivity or purity. Customers can forget the anxiety that comes from receiving 'aged stock' or material that needs urgent usage. We found that the biggest offenders in shelf-life reduction are poorly managed warehouse humidity and exposure to contaminated handling atmospheres. This led us to double down on our packaging investments. Every Claviculin container includes triple-layered moisture barriers, internal sealing, and clear labels showing packing dates for tracked rotation.
From our years of experience, it became clear that some users store chemicals under conditions that drift far from what suppliers put in the notes. You will not find vague instructions here; we worked with supply chain managers to run pilot storage studies at a range of common warehouse setups, from climate-controlled to open-shed, and built our recommendations from these findings. In cases where operator habits or equipment maintenance lapsed, we saw minor caking or flowability loss, but never catastrophic quality failures attributable to our manufacturing process. This offers end users peace of mind, as our operational discipline in production matches the controls found on the client side.
Many products in this class appear interchangeable on paper. We have routinely sourced and benchmarked competitor products, both domestic and international, to check Claviculin's reliability and purity. Some materials sold as equivalents arrive with inconsistent color, odor, or pH readings that suggest incomplete reactions or hasty purification. We have seen shipments from competitors carrying tags that don't match stated batch records, an obvious risk for regulated industry customers.
Because of our vertical integration, almost everything that goes into Claviculin is produced or controlled within our own facilities. We have invested heavily in automated monitoring, which reduces human error at both the mixing and packaging stages. Every raw material batch is stored and barcoded in a separate contained zone to avoid confusion or cross contamination. These investments translate into reduced complaints, lower out-of-spec incidents, and lasting relationships with partners who need a material they can count on through multiple years, audits, and product launches.
Not every manufacturer of this compound maintains such rigorous process discipline. We have encountered suppliers with product lines that drift in quality over time due to inconsistent sourcing or frequent last-minute process changes. When customers switch to Claviculin, the differences become clear: clearer documentation, more reliable shipment scheduling, and the ability to trace every lot right back to the moment of synthesis. Many buyers see Claviculin as not just another additive or intermediate, but as a critical link in their process stability chain.
Experience proves that open dialogue between manufacturer and user leads to smoother process rollouts. Our technical support teams do not shy away from on-site troubleshooting sessions, process optimization walkthroughs, and in-depth root cause analysis on any issue—even when it isn't clearly related to Claviculin. Over years of these engagements, we have accumulated a knowledge base that our partners regularly tap for advice on scaling options, venting setups, and alternative purification approaches.
Our willingness to welcome external technical staff into our facilities has often surprised customers used to closed-door attitudes. We invite open-book audits, complete with operator interviews, line walkthroughs, and unrestricted QA documentation review. These experiences have fostered both trust and a more realistic understanding of what a manufacturer can deliver. Partners walk away with practical insights for their own operations, while we gather honest feedback that often feeds future upgrades to the Claviculin process.
Global chemical regulations evolve constantly, often in directions that catch even experienced operators off-guard. Our product stewardship team remains alert for impending bans, new disclosure rules, and changing labeling requirements. We revisit our own raw material selection, reaction control, and waste management practices with every new standard published. Beyond compliance, we regularly advise customers on the real-world implications of new rules, helping them anticipate adjustments that keep their products competitive and safe.
At times, sudden market shocks—natural disasters, plant incidents, shipping crises—have briefly shaken specialty chemical supply lines. We have worked through these crises before, including temporary production relocations and new packaging solutions when traditional suppliers failed. By maintaining strong, trusted relationships with upstream raw material sources, we have kept Claviculin available and on specification even during supply crunches that saw some peers place customers on allocation. Our focus stays firmly on long-term reputation rather than short-term sales, guided by lessons learned over decades dealing with unpredictable events.
As industrial buyers and regulators place more weight on chemical lifecycle management, we must take direct responsibility for any impact our product might have. Early generations of similar compounds sometimes suffered from waste streams that caused problems in downstream water treatment or air emissions compliance. We engineered our manufacturing footprint to minimize these concerns—closed-loop solvent recovery, robust dust control, and regular reviews of our emissions reports all came out of audits and feedback sessions rather than minimalist reading of the letter of the law.
We provide clear and up-to-date handling guidelines derived not only from written codes but also from practical safety walkthroughs with partner EHS staff. We continue to coach warehouse operators on proper PPE, storage, and spill recovery based on real near-miss data from our own plant environments. Our safety improvements do not stop at our gate; we partner with interested customers for joint EHS reviews and process hazard analyses as soon as we see a trend or emerging risk.
Since the debut of Claviculin, our product has seen usage in both small pilot batches and sustained 24/7 plant operations across three continents. We monitor feedback from every segment, tracking both formal complaints and positive results such as reduced batch failures and lower need for rework. Case studies sent in from users running critical API syntheses or high-throughput crop protection lines show that process stability improves after substituting previous intermediates for Claviculin. Less downtime, simpler cleaning, and improved final yields all represent victories won on the shopfloor instead of only in a lab notebook.
It sometimes surprises new buyers that feedback loops run both ways here. Several optimizations to the current Claviculin 187-CX model came directly from shop floor observations. An incident where an older packaging approach led to clumping led us to redesign our interior lining. Discussions about solubility behavior during a scale-up prompted a slight adjustment to our drying protocol. Rather than viewing complaints as risks, we see them as valuable data points. Internally, we maintain a "lessons learned" dashboard to drive continual improvement and to make sure no problem slips through the cracks—an approach that sets us apart from operations that resist change or bury inconvenient feedback.
As a manufacturer, our role does not end at shipment or after an invoice clears. Each customer using Claviculin inherits not just a product off the shelf, but a partner who actively supports their R&D and production pipeline over time. Our aim remains clear: deliver a product that preserves line stability, respects worker safety, simplifies regulatory compliance, and runs strong through industry ups and downs.
Claviculin serves as a working example of how direct experience in the field shapes every day of our production cycle. The collective expertise of our chemists, production techs, storage managers, and regulatory leads comes together in every container. We believe the best results come from open discussion, honest reporting of issues, and direct action when challenges emerge. This foundation allows Claviculin to keep building trust among our growing base, through each audit passed, each quality report confirmed, and each success story coming back from process experts on factory floors.